NCBI PubMed Centralopen access
Intranasal Delivery of an RSV A2-Derived Pre-F VLP Vaccine Induces Robust Mucosal and Systemic Immunity Against RSV B Strain Without Enhanced Disease.
distributed systems architecture
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 345243
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.